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The molecular biology of Ca2 channels has its origins in the
biochemical characterization of the skeletal muscle dihydropyri-
dine receptor. These studies established that the dihydropyridine
receptor/channel complex was a multi-subunit complex composed
of a1 (the ion-conducting subunit), and smaller accessory subunits
(a2, /3, and y). These subunits were purified, sequenced, cloned,
and expressed. Cloning of these cDNAs provided the probes to
discover the molecular diversity of Ca2 channels. To date (April
1995), genes for six a1s, four /3s, one a2, and one y have been
cloned. Preliminary classification schemes divided native calcium
channels into low voltage-activated (T-type) and high voltage-
activated types: L-type, dihydropyridine-sensitive; and N-type,
w-conotoxin GVIA-sensitive. The development of new toxins has
led to the further subclassification of high voltage-activated
channels to: P-type, which is blocked by w-agatoxin-IVa from the
funnel-web spider Agelenopsis aperta; Q-type, which is blocked by
w-conotoxin-MVIIC from the marine snail Conus magus; and
R-type, which is resistant to most toxins (DB Wheeler, A Randall,
and RW Tsien, Science 264:107—111, 1994). Expression studies
with cloned a1s have proven that this subunit determines the
voltage and pharmacological sensitivity of the channel. This
should allow us to classify the cloned a1s in terms of their type.
Unfortunately these properties are affected by the choice of
expression system, and the subunit composition of the channel.
Despite these complications, the six a1s have been classified as
follows: three a1s (ais, aic, and aiD) belong to the L-type
(dihydropyridine-sensitive); aIB is an N-type; alA is a P-type
although it has also been classified as Q-type; and alE, which does
not display any distinctive pharmacology, has been called an
R-type (resistant). We will review the cloning, classification, tissue
distribution, and functional expression of these a1 subunits and
the accessory subunits.
Molecular biology of the skeletal muscle L-type ,a1
Biochemistry
Skeletal muscle provided an excellent source for the purifica-
tion of L-type Ca2 channels since it contains functional channels,
and a high density of dihydropyridine (DHP) receptors [11. Due to
the ability of DHPs to affect channel activity, it was assumed that
DHP receptors were either on the channel itself or at least closely
associated with it. A second important feature of DHPs is that
they bind to the receptor/channel with high affinity and dissociate
slowly, thereby providing a marker to follow the purification of the
receptor. Typically, skeletal muscle t-tubule membranes were
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prelabeled with tritiated dihydropyridines, solubilized by digitonin
or CHAPS, and purified through wheat germ agglutinin chroma-
tography, anion exchange chromatography, and sucrose gradient
centrifugation [2—5]. The calcium channel activity of purified DHP
receptors was measured after reconstitution into lipid bilayers [6].
Early work revealed the presence of at least three proteins in
the purified preparation, termed a, /3, and y. However, in 1987 the
existence of two as became apparent [7—10]. Azidopine photola-
beling studies showed that the DHP binding subunit was a 165 to
190 kD protein whose mobility in SDS-PAGE gels was not
affected by reducing agents. In contrast, the other protein at —170
kD, a26, can be dissociated under these conditions, decreasing its
mobility to 142 kD (a2) and 22 to 28 kD (8). In addition, the
purified complex contained a 55 kD /3 subunit and the 32 kD y
subunit. All these subunits have been purified, sequenced, and
cloned [11—15]. The sizes of the purified proteins agree quite well
with the sizes deduced from the primary sequence, except a1,
which appears smaller in the purified preparations. At best, trace
amounts of the full-length 214 kD a1 have been detected [16, 17].
This size discrepancy is due to proteolytic processing of the
carboxyl terminus either in vivo or during the purification process
[17]. In addition, the a subunit of G copurifies with the DHP
receptor [18], supporting the notion that there is a direct pathway
between G and L-type Ca2 channels.
An important feature of L-type calcium channels is that their
activity is stimulated by cAMP-dependent protein kinase (PKA)
phosphorylation. Although this regulation may play a more
important role in cardiac function [1], a similar cascade operates
in skeletal muscle [19, 20]. PKA phosphorylation stimulates the
activity of the purified receptor/channel complex [6], and leads to
phosphorylation of both the a1 subunit [21, 22] and the /3 subunit
[23, 24].
Cloning of the skeletal muscle a1 subunit
Cloning of the skeletal muscle a1 subunit was accomplished by
purifying tryptic peptides derived from the DHP receptor, deter-
mining the sequence of these fragments, preparing degenerate
oligos based on this sequence, and screening of rabbit skeletal
muscle cDNA libraries with these oligos [11]. Although this a1
cDNA has been called many things (pCAC6 [25], or CaChi [26]),
it is now called a1. The full-length cDNA of the rabbit skeletal
muscle DHP receptor has an open reading frame that encodes a
protein of 212,018 D. Its sequence has 55% similarity to the Na
channel a subunit, and like the Na channel, it contains four
internal repeats, termed Domains I, II, III, and IV. These
structural motifs are found in all the cloned Ca2 channel a1
subunits. Secondary structure analysis predicts eight membrane
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Fig. 1. Oligomeric stnwture of voltage-gated
Ca2 channels. This cartoon shows the general
structure of a Ca2F channel. The dimensions
are only approximate. Membrane spanning (or
embedded) regions are shaded. The a2 sobunit
is shown to he in the extracellular spaceIntracellular
according to [1211. The regions where n and /3
interact is from [139, 140]. The regions where
n28 and y interact is not known. /3 is shown to
contain five helices, the second helix can be
deleted by alternative splicing in /3 and /2,
while it is missing in /33 and /34. The secondary
structure prediction programs indicate
numerous possible heliees, but for simplicity
only the longest are shown.
spanning regions in each domain of voltage-gated Ca2 and Na
channels (Fig. 1, abbreviated 151, for Domain I, transmembrane
segment 1) [271. This model predicts that the amino and carboxyl
termini are located inside the cell, and that there are long
cytosolic loops that connect each domain.
Similar a cDNAs have been cloned from carp [28], mouse
skeletal muscle [29], mouse ovary [26], and mouse BC3H1 cells
[26]. The human a15 gene was localized to chromosome 1q31q32
[301. The mouse skeletal muscle cDNA was cloned from muscular
dysgenic (mdg) mice. In this mutant there was a single nucleotide
deletion that resulted in a frame shift and termination prior to the
domain IV S6 loop. Apparently this truncated a1 is not a
functional channel [25].
The a15 gene is alternatively spliced in at least one location,
after the IV S3 segment. This splice variation, which appears to be
due to exon-skipping, has been detected with both PCR and
eDNA library screening [26, 31]. All three L-type Ca2 channel
genes are spliced in this same area [26]. The functional signifi-
cance of this splicing remains a mystery. A second mystery centers
on the existence of a two-domain isoform [32], which recent
studies have failed to confirm [31].
Northern blot analysis of RNA from different tissues identified
a 6.5 kb transcript of a15 in skeletal muscle from rabbit [12, 33],
carp [28], mouse [291, and mouse BC3HI cells [33]. However, its
expression appears limited to skeletal muscle since little or no
hybridization was detected in heart, brain, trachea, lung, ileum,
stomach, or kidney [12, 33]. One exception may be aorta, where it
was detected by Koch et al [34], but not by Ellis et al [12].
Functional expression
A popular system for expressing cloned ion channels is the
Xenopus laevis oocyte [35]. Unfortunately, microinjection of a15
cRNA did not lead to the expression of functional Ca2 channels
(measured with Ba2), even when injected with auxiliary subunits
(Perez-Reyes, unpublished observations). Therefore, we chose
stable transfeetion of mouse L cells as an expression system [36].
These studies proved that expression of a15 without any other
subunits led to the induction of functional Ca2 channels. Sur-
prisingly the activation kinetics of these currents was extremely
slow, suggesting a role for the other subunits. To test this
hypothesis we coexpressed the skeletal muscle /3 with a15 in L cells
and indeed, coexpression of /3 with a1 led to a normalization of
the current kinetics [37]. This coexpression also led to fivefold
increases in high-affinity DHP binding sites. Paradoxically there
was not a corresponding increase in the current density. Anyway,
these results showed that /3 was a subunit, which could alter the
biophysical properties of the channel and alter the expression of
DHP binding sites.
An alternate expression system used was microinjection of an
expression plasmid into cultured dysgenic mdg myotubes, which
restored both Ca2 current and skeletal muscle-like excitation-
contraction coupling, contraction that occurs even in the absence
of external Ca2 [25].
Molecular biology of the cardiac muscle L-type a1, a1
Biochemistry
Purification of cardiac Ca2 channels has been hampered by a
low density of DHP binding sites in sarcolemmal membranes from
heart [38]. Despite this limitation, the channel has been purified
from various species. These studies have identified at least three
subunits of the L-type Ca2 channel: (1) an a1, whose apparent
molecular weight is between 165 and 195, (2) an a23, and (3) a /3
[39—45].
In contrast to skeletal muscle preparations, PICA phosphoryla-
tion of purified cardiac a1 was not observed in purified heart
preparations [42, 43, 46, 47]. The size of the purified a1 is much
smaller than the size deduced from the eDNA clone, suggesting
proteolysis. Similar to the skeletal muscle a1 this truncation
occurs at the carboxyl terminus, since antibodies directed against
this region only recognize a minor full-length form (242-kDa) in
heart and brain preparations [45, 48]. Yoshida et al [48] showed
that only this long form could be phosphoiylated by PICA.
The purified cardiac DHP receptor also contains a 170 kD a26
subunit, which after reduction is split into a 140 kD a2 and a 30 kD
8 [42—44]. This a25 is either identical to the skeletal muscle form,
or a splice variant.
The cardiac /3 was purified using a specific anti-peptide anti-
body directed against the /33 sequence [47]. This antibody immu-
noprecipitated DHP-labeled receptors from a solubilized canine
cardiac preparation, thereby proving that /32 is the predominant /3
in heart. Back-phosphorylation studies showed that in vivo isopro-
terenol treatment lcd to the phosphorylation of /33 [47].
Cloning of the cardiac a1
The air (CaCh 2, CARD, or rbC) eDNA was cloned from
rabbit heart eDNA libraries using low stringency hybridization
1112 Perez-Reyes and Schneider Ca2 channels
a1
Perez-Reyes and Schneider: Ca2 channels 1113
I II III
L1 ais i—i_______
S3—S4
P/Q alA I I
N a1 B
A a1 E
Fig. 2. Alternative splicing of a subunits. The regions where alternative splicing of exons occurs is shown by the hatched boxes. Insertion/deletions (of
> 10 amino acids) are shown by the thick line. The diagram is roughly to scale.
with skeletal muscle a1 cDNA as probe [49]. Its full-length cDNA
contains an open reading frame that encodes a protein of 242,771
D. This protein is 66% similar to css. The human cardiac ac has
also been cloned and its gene mapped to chromosome 12p13 [501.
Northern analysis detects aic expression in heart, brain, aorta,
trachea, and lung [33, 49, 50]. Expression of a has also been
detected in the following tissues and cell lines: kidney [51], mouse
ovary [26], pancreas [52], colonic smooth muscle [53], fibroblasts
[54], HIT cells [26], GH3 cells PC12 cells [55], NE-I 15 cells
[55], and AT-20 cells [55]. In addition, a is transiently expressed
in skeletal muscle during development [56].
Comparison of the published sequences reveals that this gene is
alternatively spliced in at least six regions (Fig. 2). Due to the
inherent difficulties in isolating an 8.5 kb cDNA, it has been
difficult to decide if there are truly tissue specific forms of aic. In
other words, are all six splice regions coordinately regulated, or
are there really 64 differently spliced cxs? At least one region
appears to be spliced in a tissue specific manner, which is the
amino terminus, where there is a cardiac specific form while the
shorter variant is expressed in smooth muscle and brain [33]. The
relative abundance of the two alternatively spliced IV S3 segments
has been found to vary between brain regions [57] and develop-
ment [58, 591 Although the functional significance of each of
these splice sites has not been determined, a difference was noted
between the cardiac and lung versions (3 alternatively spliced
regions) in terms of their sensitivity to the DHP antagonist,
nisoldipine [60]. These results suggest that splicing of a1 may
contribute to the selectivity of DHP antagonists for smooth
muscle over cardiac L-type Ca2 channels. However, the only
full-length vascular smooth muscle aic cloned [61] does not
contain the splice variant regions found in the lung clone. Other
strange splicing events, which are not predicted to encode func-
tional channels, have also been reported [54, 62].
Functional expression
Injection of a1 cRNA into Xenopus oocytes leads to the
appearance of dihydropyridine-sensitive Ba2 currents [49, 50, 63,
64]. In contrast to the stable transfection systems required to
express ais, oocytes provided an easy assay system to test the
effects of auxiliary subunits. Mikami et al [49] showed that a2h
could increase aic currents approximately twofold, with no
apparent changes in the properties of the channel. Similar results
were reported by Biel et al using the lung variant of aic [65].
Bolstered by our experience with the skeletal muscle p, we
recloned the cardiac a1 and coexpressed it with j3 [63]. We found
that /3 not only caused an increase in the amplitude of the
currents, but also shifted the voltage-dependence of activation
and accelerated the rate of activation. We have also found that all
ps modulate aic activity similarly. These effects can be classified
as either quantitative, /3s increase the amount of functional
channels, or qualitative, /3s affect the biophysical properties of the
channel.
Coexpression of ywith aic has little or no effect on the currents
in oocytes, although coexpression of y with aicf3ia led to a small
increase in the currents [63]. In contrast, Singer et al [64] reported
that y had profound effects on inactivation. Many results of this
paper [64] have been difficult to reproduce, and their currents
were likely contaminated with endogenous oocyte channels [66,
67]. Interestingly, these endogenous channels are regulated by
mammalian subunits [64, 68]. For example, the /3 subunit alone
Iv
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Table 1. Cloning and expression of cloned calcium channel a1 subunits
Carp [28]
Mouse (mdg) [29]L ac Rabbit heart [29]
Rabbit lung [65]
Rat aorta [61]
Mouse brain [154]
Rat brain [57]
Human fibroblasts [54]
Human heart [50]
L3 a10 Hamster HIT [80]
Human pancreas [79]
Human brain [68]
Rat brain [78]
PlO a Rabbit brain [84]
Rat brain [85]
N a,8 Ray [111]
Rat brain [103]
Rabbit brain [104]
Human brain [102]
Mouse brain [105]
R am Ray [1111
Rat brain [110]
Rabbit brain [109]
Human brain [112, 113]
Mouse brain [113]
Oocytes [49], CHO [60], COS [132],
HEK [74], Sf9 cells [72]
Oocytes [65], CHO cells [60]
Oocytes [153]
Chromaffin cells [154]
Oocytes [155]
Oocytes [50]
Oocytes [68]
Oocytes [86]
Oocytes [114]
Oocytes [110]
Oocytes [112] and HEK-293
cells [113]
Pharmacology
Dihydropyridines, verapamil,
diltiazem, [152]
Dihydropyridines
Dihydropyridines
Dihydropyridines
Dihydropyridines
Dihydropyridines
w-CTx-MVIIC, a-agaIVA
w-CTx-MVIIC, -agaIVA
w-CTx-G VIA
a-CTx-G VIA
w-CTx-G VIA
Resistant
Resistant
can increase these currents up to 500 nA [69]. This contamination
by endogenous currents casts into doubt many studies where a1ç
expression was low (< 100 nA) [70, 71].
Other systems used to express ajc include: baculovirus infec-
tion of the insect cell Sf9 [72, 73], COS cells [74], CHO cells [48,
75], L cells [761, and HEK-293 cells [74]. These studies have
verified the essential role of f3 in increasing the functional
expression of DHP binding sites and channel activity [76, 77].
Molecular biology of a neuroendocrine L-type ,
Cloning of alD
Three approaches were used to clone a third L-type a1 (CaCh
3, rbD): (1) low stringency hybridization using cr eDNA as probe
[68, 78], (2) PCR [26, 79], and (3) oligonucleotides based on
conserved regions between ais and a1 [80]. The human aID was
cloned from pancreatic islet eDNA libraries [79]. The human gene
was localized to chromosome 3 [81].
The deduced amino acid sequence is very similar to aic. Even
the location and sequence of alternatively spliced regions are
similar (Fig. 2). In addition, novel splice variants of the carboxyl
terminus have been cloned. One of these versions is considerably
shorter than any of the other L-type a1s (whose C termini make
up to 30% of the protein). Two size forms of aID have also been
detected in immunoprecipitates from brain preparations [45].
Analysis of the distribution of aiD using Northern blots has
been complicated by the cross-reactivity of the three L-type a1s.
For example, in one study the aID probe cross-reacted with a 6.5
kb mRNA in skeletal muscle and aorta (presumably ais) [78]. A
second confounding factor is that a1 and aiD have similarly sized
mRNAs (8.5 vs. 8.6, respectively). In a second study using the 5'
untranslated region, which bears no sequence homology to a
(although it is surprisingly conserved across species, [82]), de-
tected expression in brain and pancreas, with traces observed in
cardiac and skeletal muscle [80]. The cross-reacting species de-
tected in heart was slightly smaller than the mRNA in brain and
pancreas.
Despite these complications, aiD is clearly expressed in the
following tissues and cell lines: pancreas [79, 80], brain [68, 78],
kidney [51], ovary [26], GH3 cells [55], PC12 cells [55], NE-115
cells [55], and AT-20 cells [55]. The distribution in brain was
mapped by PCR [68, 80], in situ hybridization with eDNA probes
[831, and immunofluorescence with antibody probes [45].
Functional expression
Despite having been cloned by so many groups, only the human
brain aID has been expressed [68]. Injection of a cRNA into
oocytes did not lead to the appearance of detectable currents.
However, coinjectiori of a2S and J3 with a did lead to the
appearance of DHP-sensitive currents. Surprisingly, injection of
a2 and f3 without aID also led to the appearance of currents,
however, these currents were not DHP-sensitive. This result
suggests that mammalian subunits can boost the expression of
endogenous oocyte channels. A second surprising result was that
the alDa2I3-induced currents were partially blocked by a high
concentration of o-conotoxin (Ctx) GVIA [68]. Although this
result may be expected on the sequence similarities between L
Type a1 Source
L, au Rabbit skeletal muscle [11, 12]
Accession# Expression
M23919, X05921 L cells [361
M37203
L06234
X15539
X55763
M34364
L01776
M67515, 6
M92269
L04569
M83566
M76558
M57682
X57476, 7
X57688, 9
M64373
L12532
M92905
D14157
M94172, 3
U04999
L12531
L15453
X67855
X67856
L27745
L29384
L29385
L29346
Oocytes [84, 90]
Oocytes [107]
Myotubes [104]
HEK293 cells [108]
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Table 2. Cloning and expression of calcium channel a2, f3, and y subunits
Subunit Splice variant Source Acession# Tissue distribution Expression with a1
a2u aza Rabbit skeletal muscle [121 M21948 Skeletal muscle Increases a1 currents in occytes [49],
increases binding [118]
azh
02c, a24, a2
Rat [123]
Human brain [68]
Human aorta [1081
M86621
M76559
Brain
Brain
Aorta
Increases binding and currents [108]
13 13ia Rabbit [13] M25817 Skeletal muscle Increases currents, shifts IV [631, alters
kinetics [37], increases binding [37]
13z
131h
13za
Mouse (unpublished)
Human skeletal muscle [130]
Human heart [1291
Rat [156]
Human brain [130, 108]
Human heart [129]
Human brain [68, 130]
Human heart [129]
Rat brain [132]
Rabbit heart [71]
M25514
M92301
L06112
X61394
M92303
L06110
M76560
M92302
L06111
M80545
X64297
Skeletal muscle
Skeletal muscle
Heart
Brain
Brain
Heart
Brain, heart, spleen
Heart
Brain, heart, lung
Brain, heart, aorta
Increases binding [108]
Increases binding [108]
Increase currents, shift IV [132]
Increase currents [71]
I32h Rabbit heart [71] X64298 Brain, heart, aorta Increase currents [71]
132c Rabbit brain [71] X64299 Brain
13 Human brain [133] Brain
f3 Rat brain [134]
Rabbit heart [71]
Human brain [135]
M88751
X64300
L27584
X76555
U07139
Brain, lung
Brain, aorta, trachea, lung
Brain, ovary, and colon
Increases currents, shifts IV, affects
inactivation [134]
Increase currents [711
Increases currents [135]
134 Rat brain [1361 L02315 Brain, kidney Increases currents, shifts IV, affects
inactivation [136]
y Rabbit skeletal muscle [14, 15]
Human skeletal muscle [125]
M32231
L07738
Skeletal muscle, lung
Skeletal muscle
Little or no effect on currents [63]
and N-type channels, an alternate explanation is that o-CTx-
GVIA was blocking the endogenous oocyte channel [69]. Appar-
ently oocytes can express two Ca2 channels, an N-type and a
T-like channel [69].
Molecular biology of a brain a1, alA
Cloning of alA
The alA cDNA (CaCh 4, BI, or rbA) was cloned using low
stringency hybridization of rabbit and rat brain cDNA libraries
using the skeletal muscle ais eDNA as probe [84, 851. Its sequence
is approximately 40% identical to the L-type a1s. In general the
membrane spanning regions are well conserved, while the con-
necting ioops are not.
Splice variation occurs in three regions (Fig. 2). The two
carboxyl terminus variants were termed BI-1 and BI-2. The rat
and rabbit sequences differ in seven regions within the long 11-111
loop; one region is due to alternate splicing of exons while the
other six are insertion/deletions. In PCR of kidney eDNA, a small
deletion was found in the same region (IV S3-S4 loop) as
described for the L-type a1s [26, 51].
Northern blot analysis indicates that alA is predominantly
expressed in brain, with much less detected in heart, and none in
skeletal muscle, stomach, or whole kidney [84]. Northern analysis
of different brain regions showed high expression in cerebellum,
but it was also found in hippocampus, olfactory bulb, and spinal
cord [85]. In situ localization studies detected alA RNA through-
tout the rat brain with higher levels found in the cerebellum,
cerebral cortex, and hippocampus [86]. By using mice with
different types of cerebellar degeneration, it was found missing in
mice with Purkinje cell degeneration [84]. Its expression has also
been detected in kidney cortex, where it is expressed in the distal
convoluted tubule [51].
Functional expression
Injection of alA cRNA into oocytes led to the appearance of
small Ba2 currents [84]. Coexpression with y had no effect, while
currents were increased by either a2h (3-fold), or 13 (20-fold) [84].
Coexpression with both a2h and /31 stimulated the currents over
200-fold to 6.5 isA, showing a synergistic action. Single channel
analysis showed that this channel had a conductance of 16.5 pS in
110 mM Ba2 [84]. Coexpression with 131b or 133 shifted the
current-voltage curve to more negative potentials and accelerated
inactivation kinetics [86]. Surprisingly, /3za slowed inactivation
kinetics [86]. This slowing of inactivation kinetics has also been
observed on the endogenous T- and N-type oocyte channels [69],
as well as with alE [87].
The pharmacology of the alA-induced currents has presented a
quandary in the classification of this channel, leading to its
classification as both P-type (w-agatoxin IVA sensitive) and
Q-type (w-CTx MVIIC sensitive) [88]. It was insensitive to DHPs
and w-CTx GVIA, but could be blocked by crude venom from the
funnel-web spider, Agelenopsis aperta [84]. This result, along with
its distribution in cerebellar Purkinge neurons [89], suggested that
alA represented a P-type channel. However, the crude venom
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contains many toxins capable of blocking high-voltage activated
Ca2 channels. The expressed channel was blocked by o-agatoxin-
IVA, which is selective for P-type channels [86, 90, 911. However,
P-type channels in vivo are -100-fold more sensitive to w-aga-
toxin-IVA, and 10-fold less sensitive to w-CTx MVIIC, than
alA-induced currents in oocytes [90]. These differences led to the
suggestion that alA represents a new type of channel, termed
Q-type [88]. However, these pharmacological differences may be
the result of other differences, such as either improper post-
translational modifications, interference from endogenous oocyte
channels, splice variations, or subunit coexpression. Similar dis-
crepancies between native cardiac L-type channels and cloned a
channels were noted [90]. For a1(, both splice variations [601 and
subunit coexpression [371 have been shown to affect the channel's
pharmacology.
Molecular biology of an N-type channel, aIR
Biochemistty
The N-type Ca2 channel was purified from brain using w-CTx-
GVIA as a marker [93, 94]. The purified channel has also been
reincorporated into lipid bilayers, where it displayed functional
activity [95]. Similar to L-type Ca2 channels, the purified com-
plex contains an a1 (ai), a2b, and a /3 (/3) [94]. Other proteins
that have been purified with the w-CTx-GVIA receptor are: a
95-kDa protein [94], syntaxin and synaptotagmin [961, and the a
subunit of G0 [97]. Apparently Ca2E channels can be bimodally
regulated by direct interaction with G proteins; they are inhibited
by G0 [98, 99] and stimulated by G [100].
Antibodies, raised against peptides from the deduced amino
acid sequence of either the j3 subunit or alB, can immunoprecipi-
tate w-CTx-GVIA receptors [45, 101]. The cw specific antibodies
recognized two size forms that differed in the carboxyl terminus
[45]. Similar to the L-type a1s, these two isoforms were also
differentially phosphorylated, in this case by CaM kinase II.
Cloning of aIB
The 01B cDNA (CaCh 5, BIll, rbB) was cloned by low
stringency screening of brain cDNA libraries using the skeletal
muscle a1 cDNA as probe [102, 1031. It has also been cloned
using alA cDNA as probe [104] or using PCR with primers against
conserved domains [51, 105]. A similar cDNA has also been
cloned from the marine ray Discopyge ommata [106]. The deduced
amino acid sequence of a111 is very similar (82%) to the alA
sequence, but less similar to the L-type a1s (43 to 51%); a full
matrix comparing these sequences is published in [104].
Two variants of the carboxyl terminus were reported for the
human alB [102]. Deletion/insertions of 22 amino acids have also
been reported for the Il-Ill loop [105]. The mouse gene has been
mapped to chromosome 2 [105].
Northern blot analysis identified a 9.3/9.5 kb doublet in rabbit
brain [104]. No cross-reacting species was detected in either
skeletal muscle, heart, or stomach. PCR analysis has confirmed
this lack of expression in peripheral tissues, including testis,
kidney, spleen, adrenal, liver, lung, and pituitary [103]. In situ
hybridization to mouse brain slices indicates that it has a wide-
spread, but non-uniform, distribution [105]. However, different
distributions within the brain have been noted between species
[103, 104].
Functional expression
Many systems have been used to express am. Williams et al
[102] used transient transfection of HEK-293 cells, Fujita et al
[104] used dysgenic myotubes, and Stea et al used oocytes [107].
In all these studies the resulting currents were sensitive to
o-CTx-GVIA. The single channel conductance was estimated to
be 15 pS using 110 mmvi Ba2 as the charge carrier [104].
Coexpression of a25 with a1 had little or no effect on currents
in oocytes, while /31b led to a fourfold increase in the currents, and
an acceleration of activation and inactivation kinetics [107].
Coexpression of alBa2f3lb led to even larger currents with no
change in other parameters. Similarly, in HEK-293 cells, coex-
pression of all three subunits (using stoichiometric ratios of
plasmid designed to improve the ratio of mRNA, and hopefully
protein) led to the largest currents and to the most w-CTx-G VIA
receptors [108]. Although this complex led to more receptors, the
highest affinity receptor was formed by alfl(3lh complexes. Again,
this provides evidence that subunit composition can lead to
differences in the pharmacological behavior of the channel.
Molecular biology of an R-type channel, alE
Cloning of aix
The a1 cDNA (CaCh 6, BII, rbE) was cloned by either
screening cDNA libraries with 01A cDNA as probe [109], or using
PCR with primers based on conserved sequences [110—112]. A
similar cDNA has also been cloned from rat brain [110], mouse
brain [113], human brain [112, 1131, and marine ray [114].
Again, splice variants of the carboxyl terminus have been
cloned [109]. Insertion/deletion events have also been found in
the 11-Ill loop. This loop also contains the repeated motif
R-R-H-R-R/H-R. In addition, this loop contains many consensus
phosphorylation sites. Another potentially interesting sequence
motif in a111 is the presence of two putative Ca2 binding regions
[112].
Northern blot analysis identified at least two transcript sizes in
rabbit brain [1091. This gene is expressed exclusively in the CNS,
since no signal was detected in skeletal muscle, heart, stomach, or
kidney RNA. Its distribution in brain was mapped by both
Northern analyses [1091 and in situ hybridization [110]. Significant
expression occurs in the olfactory bulb, cortex, hippocampus, and
cerebellum.
Functional expression
Robust (1 A) Ba2 currents were recorded from oocytes
injected with a111 alone [112]. Coexpression with /31b had no
apparent effect on peak currents, but did shift activation and
inactivation to more negative potentials [110]. These currents
activate and inactivate relatively quickly [114]. Comparison of the
voltage dependence of activation using similar ionic conditions
(40 mmvi Ba2) shows that a111 currents activate 15 mV more
negatively than aic currents [110]. This led to the suggestion that
alE represented a member of the low voltage-activated family
(T-type). However, T-type channels activate 50 mV more negative
than L-type channels [115]. A second major difference is that
T-type channels have a conductance of —8 pS, while a111 currents
have a conductance of 14 p5 [112].
The pharmacology of alE-induced currents is notable in that
most Ca2 channel blockers have no effect. These currents were
not affected by DHPs, phenylalkylamines, conotoxins, or FTX
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[110, 112—114]. They are partially blocked by crude spider venom,
amiloride, Ni2, and Cd2. Similarly unresponsive high-threshold
Ca2 currents have been described in neurons [116], [92]. These
resistant currents have been attributed to a new type of channel
called R-type. Since these currents share kinetic and pharmaco-
logical characteristics, it has been suggested that ai represents
an R-type channel [92].
Molecular biology of a2
The a2 subunit is a large glycoprotein that binds well to
wheat-germ agglutinin affinity columns. It was this property, and
the ability of CHAPS or digitonin to solubilize the Ca2 channel
as a complex, that allowed purification of skeletal muscle a1.As
discussed earlier, a2 was originally believed to be the DHP
receptor. Thus, it was purified and microsequenced [12, 117, 118].
Complementary DNA libraries were screened with degenerate
oligonucleotides whose sequence was based on the microse-
quenced protein. The full-length rabbit skeletal muscle eDNA
contains an open reading frame that encodes a protein of 125,018
D [12]. The human a26 gene has been localized to the proximal
long arm of chromosome 7q [119].
The b peptide, which is bound to a2 through disulfide bonds,
was also purified and sequenced [120, 121]. Comparison of this
sequence to the cloned cs2 proved that these proteins were
encoded on the same eDNA. Apparently a2h is synthesized as a
propeptide that gets cleaved near the carboxyl terminus to form b,
however, they remain covalently linked through a disulfide bond.
Secondary structure prediction programs suggest that b contains a
transmembrane segment. This may serve to anchor the a2h
complex to the membrane (Fig. 1), since a2 can be extracted with
a high pH wash in the presence of reducing agents [121].
Northern blot analysis detects 7 and 8 kb transcripts for a2h
mRNA. These mRNAs are expressed in skeletal muscle, heart,
aorta, lung, ileum, and brain [12, 33]. A cross-reactive species was
also detected in Xenopus oocyte RNA [122]. Its distribution has
also been mapped by in situ hybridization of whole rat embryo
[123].
The human and rat brain a26cDNAs have also been cloned [68,
123]. While most of the amino acid differences between the rabbit,
rat, and human sequence can be ascribed to species differences,
one region appears to be alternatively spliced. PCR was used to
amplify a eDNA that encoded this region, and oligonucleotides
specific for the inserted sequence were used to screen Southern
blots of the PCR reaction. This study [68], and a second study
using rat tissues [123], showed that the first inserted sequence,
referred to as a2a, was only expressed in skeletal muscle, while the
deleted version, a2h, was expressed in aorta and numerous brain
regions. In addition, PCR of human aorta has identified a2
variants that lack both of these small exons (a2 and a2d), as well
as identifying a third exon that that is occasionally skipped [108].
The functional significance of these variations is unknown.
The expression of a26 with a1s appears to enhance the expres-
sion of a1, especially in the presence of the other accessory
subunits, such as f3. This suggests that a2h may play a role in
determining the spatial distribution of Ca2 channels. It appears
that all Ca2 channel types contain a2h, although this has only
been proven biochemically for the brain N-type [94] and the
L-type channels in skeletal and cardiac muscles. Coexpression of
a2ah with aic in CHO cells led to an acceleration of inactivation
kinetics [124]. In contrast, coexpression of a2ah with alB does not
affect kinetics [108].
Molecular biology of y
The y protein was purified from skeletal muscle as a complex
with the DHP receptor. The protein was sequenced, oligonucle-
otides were made using this sequence information, and its cDNA
was cloned from skeletal muscle eDNA libraries [15]. It was also
cloned using antibodies against y to screen a Agt-11 expression
library [141. The deduced amino acid sequence encodes a protein
of 25 kD, which contains four putative membrane spanning
regions.
The human y has been cloned from both cDNA and genomic
DNA [125, 126]. The human gene was localized to chromosome
17q24.
Northern blots show that y is almost exclusively expressed in
skeletal muscle [14, 15], although similarly sized transcripts were
detected in lung [141 and aorta [331. PCR results have confirmed
this restricted tissue distribution [125].
Expression studies have not determined what role y plays in the
Ca2 channel complex. Its almost exclusive expression in skeletal
muscle suggests that it may have a role in excitation-contraction
coupling.
Molecular biology of f3
Biochemistry
Skeletal muscle /3 was purified with the DHP receptor. The
ability of antibodies prepared against this 55 kD protein to
precipitate bound DHPs proved that it was part of the receptor!
channel complex [127]. In vitro treatment of purified DHP recep-
tor preparations with PKA or PKC leads to the phosphorylation
of both a1 and /3 [128]. The phosphorylation of /3 occurs on at
least two residues: Ser-182 [131 and Thr-205 [16].
Cloning of 1:3,
The eDNA was cloned using oligonucleotides based on the
protein sequence of a fragment of the 55 kD /3 [13]. Its eDNA
contained a 1.8 kb open reading frame encoding a protein of 58
kD. Secondary structure analysis predicts that the protein con-
tains many a helices. These helices contain many charged amino
acid residues, indicating that they are probably not embedded in
the lipid membrane. The deduced amino acid sequence also
contains interesting motifs such as heptad repeats, PEST se-
quences, and consensus sequences for many protein kinases [13].
The /3 gene is alternatively spliced in two regions to form at
least three full-length proteins (a fourth splice variant, /3 tr'
appears to result from a splice error that causes a jump in the
open reading frame and truncation). One insertion!deletion re-
gion occurs in the middle of the sequence (Fig. 3); the brain
variants (/31b and Pic) lack an exon used in skeletal muscle j31a that
encodes 52 amino acids. The second region is the carboxyl
terminus, where alternate exons encode a short (Iia and 13) or a
long tail (/31b). Similarly spliced forms have been detected in
human heart and brain [68, 1291. The human gene has also been
cloned [130]. The genomic structure confirms that these alternate
forms are derived from splicing of one gene. The human gene was
localized to chromosome 17 [131].
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Fig. 3. Alternative splicing of /3 subunits from the
cloned splice variations. We have constructed a
simplified diagram showing a model of the
consensus gene. Exons showing sequence
identity are marked in a similar manner. The
diagram is roughly to scale. The exons that are
skipped in the trunctated forms are shown by
dotted lines. The exon that contains the a
interaction domain is labeled AID.
Functional expression
In contrast to ah and y, coexpression of 13 with a leads to
profound differences in the expression of functional channels and
in their biophysical behavior. These studies on skeletal muscle a1
showed that 13 could affect activation kinetics and increase the
number of DHP binding sites, however, there was no change in
current density [37]. Other coexpression studies have used heter-
ologous expression of I3 with other a subunit types.
Coexpression of f3 with cardiac a also leads to increases in
the number of DHP binding sites [1321, and as one would predict,
it increases the expressed current [63]. In oocytes, we found that
p increased the peak currents, accelerated activation, and shifted
the voltage dependence of activation to hyperpolarizing potentials
[63].
Coexpression of with N-type a in oocytes also led to
increases in the currents and altered their kinetics [107]. However,
no effect was observed on the voltage dependence of activation.
Studies expressing a111 in HEK-293 cells have shown that 13
increases the number of w-CTx-GVIA receptors [108].
Coexpression of l3 with brain alA in oocytes also led to an
increase in the measured currents [84]. However, /3 did not affect
the kinetics of this current. These results show that I3 can interact
with many types of a1. The most obvious affect of this interaction
is to increase the currents measured.
Molecular biology of fi2
Cloning of 132
During our screening of rat brain eDNA libraries with 131a we
found two types of clones: one type was the splice variant, [31b'
while the second appeared to be encoded by a distinct gene [132].
Therefore, we called it /3. Using similar methods 132 was cloned
from rabbit heart [71]. A human brain /32 eDNA was cloned using
sera from Lambert-Eaton myasthenic syndrome (LEMS) patients
to screen an expression library [133]. Note, there was an apparent
sequencing error of the human 132e form (deletion of cytosine
1603), which resulted in a jump in the reading frame and an
apparent lack of homology at the carboxyl terminus [133]. How-
ever, addition of the missing nucleotide restores an open reading
frame that is nearly identical to the rat and rabbit /32s.
The /32 gene is alternatively spliced in at least two regions (Fig.
3). Two versions of the amino terminus were cloned from rabbit
heart: one form was identical to the rat brain so it was called f32a,
while the other form had a unique amino terminal sequence
suggesting the use of an alternate exon (132b). The human brain 132
also contains a unique amino terminal sequence, which we call
I32e. The second region of alternate splicing occurs in the central
region. Apparently all four 13 genes have intron/exon junctions in
this region (Fig. 3), In the 132 gene there appears to be three exons
that are alternatively spliced in this region. PCR cloning has
detected versions where none of these three exons is used,
however, this results in a frame shift and truncation, /32tr In
contrast to /3k, alternate splicing of the carboxyl terminus has not
been detected.
Northern blot analysis detects abundant /32 transcripts in brain,
heart, and lung [132]. Lower levels of expression can also be
detected in kidney. At least thtee transcript sizes were detected (6,
4, and 3.5 kb). This size heterogeneity is probably due to both
alternatively spliced mRNAs and alternate use of polyadenylation
signals [1321.
Functional expression
Coexpression of /32 with aic has profound effects on the size
and kinetics of the induced currents. Peak currents are stimulated
over tenfold. This stimulation is largest at negative test potentials,
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which is due to /32's ability to shift the activation threshold of the
channel approximately —10 mV [132]. 132 also accelerated the
activation kinetics of cx1.
Inactivation kinetics of eric in oocytes are also affected by /32•
Note that the kinetics of in oocytes is much slower than
observed when Cric is expressed in other systems. This is especially
true of inactivation; these currents in oocytes hardly inactivate
below +20 mV test potentials (and above +20 mV there are
contaminating currents), while a1(32-induced currents partially
inactivate (600 ms i-).
Molecular biology of 133
Cloning of 13
Three approaches were used to clone /33: (1) Hullin et al [71]
used the skeletal muscle J3ia cDNA as probe, (2) we used a
PCR-based strategy using primers that matched conserved re-
gions in 13 and /32 [134], and (3) Witcher et a! [94] used antibodies
raised against the purified N-type channel /3 protein to screen a
Agtll expression library. The human /33 was recently cloned and
mapped to chromosome 12q13 [135]. The deduced amino acid
sequence of the rat f3 is 98% identical to the human 133 sequence,
while it is only ---70% identical with the other (3proteins. Most of
this similarity is in a central core region (Fig. 3), while the carboxyl
termini are more divergent. The f33 protein does not contain
consensus PKA phosphorylation sequences.
In contrast to I3 and /32, alternative splicing of 133 has not been
discovered, It expresses a small exon in the central splice site that
has a similar sequence as 131b, 132c, and 134 (consensus sequence
AKQKQKX). Although this exon can be skipped, the reading
frame is lost resulting in a truncated protein (133tr).
Northern blots show that 133 is predominantly expressed in
brain, with lower amounts detected in aorta, trachea, lung, and the
pancreatic /3-cell lines HIT and RIN [1341, [71]. In human tissues
it is found in brain, ovary, and colon [1351. Despite having been
cloned from heart, little or no mRNA is detected on Northern
blots.
Functional expression
The effects of f33 have been tested on CriC and ellA-induced
currents in oocytes [71, 86, 90, 134]. Using eric, we have shown
that 133 affects the currents as observed with other /3s; it increased
currents (> 10-fold), shifted the activation limb of the I-V curve
—7 mV, and accelerated the kinetics of activation and inactivation
[134]. In addition to altering the inactivation kinetics, /3 de-
creased the plateau current attained during long (>3 second)
pulses. These results can be interpreted as 133 altering the
equilibrium between open and inactive states. Although the other
13s had modest effects on inactivation, it is clear that 133 has a more
profound effect. Studies using LIlA reached a similar conclusion
[90].
Molecular biology of 134
Cloning of 134
/34 was cloned using PCR with primers that matched conserved
regions in I3 and 132 [136]. We then isolated a full-length cDNA
by screening a rat brain cDNA library. This cDNA contains an
open reading frame that encodes a 58 kD protein. Its sequence
also contains regions that are highly conserved in all the /3s, while
the carboxyl terminus is more divergent. A phylogenetic tree
based on sequence similarities indicates that 134 is most closely
related to the ancestral /3. Alignment of the predicted helices with
the hydropathy values shows that none of the helices are hydro-
phobic [136]. 134 does not contain any consensus sequences for
PKA phosphorylation.
Northern analysis shows that /34 is predominantly expressed in
brain, especially cerebellum [136]. Weaker expression was also
detected in kidney. The cross-reactive mRNAs were large (7 kb)
appearing as a doublet. Although this may suggest splice variation
in the coding region, none has been detected. A likely explanation
is that there is alternate use of a polyadenylation signal, as we
have found in /32 [132]. The only alternate splicing detected so far
is the deletion of the same small exon found in other /3s, Which
again leads to a frame shift and truncation (P4tr)
Functional expression
134 modulates cw1 activity the same way as /33: it stimulates the
amount of currents measured tenfold, shifts the IV —10 mV,
accelerates activation kinetics, and changes the rate and extent of
inactivation [136]. We have also tested the effect of 134 on
endogenous oocyte channels. These channels are stimulated
threefold by injection of f34. However, no effect was observed on
either the relative position of the IV curve, or on the activation
kinetics (which were quite fast already, 1 to 2 ms) [136]. A small
effect on inactivation was measured, but this effect was overlooked
until we analyzed single channel recordings, where 134 was found
to decrease the decay of T-like channels [69].
Mechanisms of a1 13 interaction
In general, /3s increase a1 activity, alter its voltage-sensitivity,
and its kinetics. Usually (3s accelerate activation and inactivation
kinetics. However, J3 interactions with other as can have other,
sometimes unpredictable, results. For example, /32 accelerates
inactivation of Cr1 [124], but has the opposite effect on ellA [86],
eli [87], and the endogenous oocyte T- and N-type channels [69].
At the single channel level we found that (32 affected the endog-
enous oocyte channels by causing reopenings of the channel.
Another notable finding was that 132 did not affect the peak P0,
which was —50%. However, /3s do increase the peak whole cell
current. This leads to the conclusion that (3s must increase the
number of functional channels on the cell surface. Our previous
studies with /3 increasing the number of DHP binding sites also
suggested that (3s increase the number of functional channels [37,
132, 136]. Immunoblot studies have suggested that /3 does not
increase the total amount of a1 protein synthesized [77, 137],
however, these studies do not address the key issue, which is, does
(3increase the amount of a1 protein expressed at the cell surface.
Studies of gating charge movement in oocytes have reached a
different conclusion [138]. Coexpression of 132 did not increase the
amount of charge movement attributed to although it did
increase the inward current. Based on the assumption that the
measured gating current reflects the number of expressed chan-
nels, Neely et al proposed that /3s facilitate the conformational
changes that occur between voltage sensing and channel opening.
Resolution of this problem requires single channel measurement
of P0. However, this is very difficult to measure because C1C has
such a low (< 0.05) and variable P0 when expressed in oocytes.
Despite a low P(, that makes it hard to count the number of
channels in a patch, Wakamori et al concluded that /3 increased P0
from 0.012 to 0,041 [66].
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These discrepancies may be reconciled if a fraction of a1
molecules are folded incorrectly, able to sense and move to
membrane voltage gradients, but unable to bind DHPs with high
affinity. /3 subunits may act as a chaperonin, helping form Ca2
channel complexes that bind DHPs and flux Ca2t In fact,
Mitterdorfer et al [137] have shown that /3 does increase DHP
binding affinity to afl-, which may have been due to this conver-
sion from low, unmeasurable binding to the typical high affinity
binding.
While the mechanisms by which /3s modulate the activity of
different a1s may vary, apparently the interaction site is well
conserved. This region was discovered by screening an expression
library made from a eDNA with 35S-labeled /3lh protein [1391.
This screening isolated many clones that encoded the domain I to
II ioop. This /3-binding domain was mapped in more detail using
site-directed mutagenesis. Little information is known about the
function of this loop, so it remains a mystery how /3 modulates a1
activity.
The site on /3 that interacts with a1 has also been mapped [1401.
In these studies the /31h subunit was truncated into progressively
smaller pieces, then assayed for their ability to stimulate alA-
induced (plus a2) currents in oocytes. The smallest fragment that
stimulated currents contained residues 211 to 245. Incredibly, this
region is nearly the same as the "common" exon (residues 217 to
243) [130], which is the first common exon found after the central
splice region (shown in Fig. 3). This exon is occasionally skipped,
leading to frame shifts and truncation. Since these truncated
forms lack this a interaction domain, they are not expected to
couple to a1. Additionally the amino terminus of /3 subunits is
capable of interacting with a1, and this interaction controls the
effect of /3s on kinetics [87].
Structure-function of a1
The significant amount of amino acid sequence identity be-
tween Na and Ca2 channels suggests that they have similar
structures. Each channel has four domains that each contains
eight membrane spanning regions. K channels have a similar
predicted structure, but only one domain; four subunits come
together to form the channel. This similarity in structure predicts
similarities in function. For example, the S4 segment of K and
Na channels has been shown to play a major role in the voltage
sensor. Although it hasn't been proven yet, it is likely that the S4
segments in Ca2 channels play a similar role.
Other regions of similarity include the pore lining domains.
These regions are highly conserved between the Ca2 channel
subtypes. Mutations in this region alter ion selectivity and con-
ductance [141—143]. These studies suggest that the selectivity filter
is formed by a spiral staircase of glutamates contributed by each
domain [142].
A very useful strategy in elucidating structure-function relation-
ships has been to make chimeras between the different a1
subtypes. Tanabe and coworkers [144] were the first to apply this
strategy to calcium channels, and by making chimeras between ais
and aic they showed that the Domain Il-Ill loop is required for
skeletal muscle excitation-contraction coupling. They have also
shown that Domain I, in particular S3 and S3-S4 linker, contains
regions involved in determining activation kinetics [145, 146].
Using similar approaches the Domain I S6 region was shown to be
involved in voltage-dependent inactivation [147], while the puta-
tive E-F hand located after Domain IV was implicated in calcium-
dependent inactivation [1481.
Dihydropyridine binding regions have also been identified using
biochemical and molecular biological techniques [149—151]. By
making chimeras between the DHP-sensitive aic and the insen-
sitive alA, Tang et at showed that one of the DHP interaction sites
is near the domain IV pore region [151]. A complete description
of the DHP binding pocket may provide insights into the three-
dimensional structure of the channel.
Summary
Pharmacological and electrophysiological studies have estab-
lished that there are multiple types of voltage-gated Ca2 chan-
nels, Molecular biology has uncovered an even greater number of
channel molecules. Thus, the molecular diversity of Ca2 chan-
nels has its basis in the expression of many a1 and /3 genes, and
also in the splice variants produced from these genes. This ability
to mix and match subunits provides the cell with yet another
mechanism to control the influx of calcium. Future studies will
describe new subunits, the subunit composition of each type of
channel, and the cloning of new Ca2 channel types.
Acknowledgments
We thank Drs. Lutz Birnbaumer and Arthur M. Brown for providing us
the opportunity and support to explore the diversity of Ca2 channels. We
would also like to thank all our fellow Baylor coworkers, in particular
Chris Wei, Haeyoung Kim, Antonio Castellano, and Antonio E. Lacerda.
Reprint requests to Edward Perez-Reyes, Ph.D., Loyola University Chicago,
Stritch School of Medicine, Department of Physiology, 2160 South First
Avenue, Maywood, Illinois 60153, USA.
References
1. MCDONALD TF, PELZER S, TRAUTWEIN W, PELZER Dl: Regulation
and modulation of calcium channels in cardiac, skeletal, and smooth
muscle cells. Physiol Rev 74:365—507, 1994
2. FLOCKERZJ V, OEKEN HJ, HOFMANN F: Purification of a functional
receptor for calcium-channel blockers from rabbit skeletal-muscle
microsomes. Eur J Biochem 161:217—224, 1986
3. STRIE5SNIG J, GLOSSMANN H: Purification of L-type calcium channel
drug receptors. Meth Neurosci 4:210—229, 1991
4. Fwp.io V, STRIESSNIG I, CATTERALL WA: Purification and reconsti-
tution of skeletal muscle calcium channels. Meth Enzymol 207:529—
546, 1992
5. SCI-INEIDER T, REGULLA S, NASTALNCZYK W, HOFMANN F: Purifica-
tion and structure of L-type calcium channels, in Methods in Molec-
ular Biology (vol 13), edited by AAR LONGSTAFF, Totowa, NJ,
Humana Press, 1992, pp 273—286
6. FLOCKERZI V, OEKEN HJ, HOFMANN F, PELZER D, CAVALIE A,
TRAUIWEIN W: Purified dihydropyridine-binding site from skeletal
muscle t-tubules is a functional calcium channel. Nature 323:66—68,
1986
7. SuARp AH, IMAGAwA T, LEUNG AT, CAMPBELL KP: Identification
and characterization of the dihydropyridine-binding subunit of the
skeletal muscle dihydropyridine receptor. J Biol Chem 262:12309—
12315, 1987
8. LEUNG AT, IMACAWA T, CAMPBELL KP: Structural characterization
of the 1,4-dihydropyridine receptor of the voltage-dependent Ca2
channel from rabbit skeletal muscle. Evidence for two distinct high
molecular weight subunits. J Biol Chem 262:7943—7946, 1987
9. VAGI-IY PL, STRIESSNIG 1, Miw K, KNAUS HG, ITAGAKJ K, McK-
ENNA E, GLOSSMANN H, SCHWARTZ A: Identification of a novel
I ,4-dihydropyridine- and phenylalkylamine-binding polypeptide in
calcium channel preparations. J Biol Chem 262:14337—14342, 1987
10. SIEBER M, NASTAINCZYK ZUBOR V, WERNET W, HOFMANN F: The
1 65-KDa peptide of the purified skeletal muscle dihydropyridine
Perez-Reyes and Schneider: Ca2 channels 1121
recptor contains the known regulatory sites of the channel. Eur J
Biochem 167:117-122, 1987
11. TANABE T, TAKESHIMA H, MIKAMI A, FLOCKERZI V, TAKAHASHI H,
KANGAWA K, KOJIMA M, MATSUO H, HIROsE T, NUMA S: Primary
structure of the receptor for calcium channel blockers from skeletal
muscle. Nature 328:313—318, 1987
12. ELLIS SB, WILLIAMS ME, WAYS NR, BRENNER R, SHARPAH, LEUNG
AT, CAMPBELL KP, MCKENNA E, KOCH WJ, Hul A, SCHWARTZ A,
HARPOLD MM: Sequence and expression of mRNAs encoding the
alpha 1 and alpha 2 subunits of a DHP-sensitive calcium channel.
Science 241:1661—1664, 1988
13. RUTH P, ROHRKASTEN A, BIELM, BOSSE E, REGULLA 5, MEYER HE,
FLOCKERZI V, HOFMANN F: Primary structure of the beta subunit of
the DHP-sensitive calcium channel from skeletal muscle. Science
245:1115—1118, 1989
14. JAY SD, ELLIS SB, MCCUE AF, WILLIAMS ME, VEDVICK TS,
HARPOLD MM, CAMPBELL KP: Primary structure of the gamma
subunit of the DHP-sensitive calcium channel from skeletal muscle.
Science 248:490—492, 1990
15. BOSSE E, REGULLA 5, BIEL M, RUTH P, MEYER HE, FLOCKERZI V,
HOFMANN F: The cDNA and deduced amino acid sequence of the
gamma subunit of the L-type calcium channel from rabbit skeletal
muscle. FEBS Lett 267:153—156, 1990
16. DE J0NGH KS, MERRICK DK, CATTERALL WA: Subunits of purified
calcium channels: A 212-kDa form of alpha 1 and partial amino acid
sequence of a phosphorylation site of an independent beta subunit.
ProcNatlAcadSci USA 86:8585—8589, 1989
17. DE JONGH KS, WARNER C, COLVIN AA, CATTERALL WA: Charac-
terization of the two Size forms of the alpha 1 subunit of skeletal
muscle L-lype calcium channels. Proc Nati Acad Sci USA 88:10778—
10782, 1991
18. HAMILTON SL, CODINA J, HAWKES MJ, YATANI A, SAWADA T,
STRICKLAND FM, FROEHNER SC, SPIEGEL AM, ToRo L, STEFANI E,
BIRNBAUMER L, BROWN AM: Evidence for direct interaction of Gs
alpha with the Ca2 channel of skeletal muscle. J Biol Chem
266:19528—19535, 1991
19. SCI-IMID A, RENAUD JF, LAZDUNSKI M: Short term and long term
effects of beta-adrenergic effectors and cyclic AMP on nitrendipine-
sensitive voltage-dependent Ca2 channels of skeletal muscle. JBiol
Chem 260:13041—13046, 1985
20. ARREOLA J, CALVO J, GARCIA MC, SANCHEZ JA: Modulation of
calcium channels of twitch skeletal muscle fibres of the frog by
adrenaline and cyclic adenosine monophosphate. J Physiol 393:307—
330, 1987
21. ROHRKASTEN A, MEYER HE, NASTAINCZYK W, SIEBER M, HOFMANN
F: cAMP-dependent protein kinase rapidly phosphorylates serine-
687 of the skeletal muscle receptor for calcium channel blockers. J
Biol Chem 263:15325—15329, 1988
22. ROTMAN El, DE JONGH KS, FL0RI0 V, LAI Y, CATrERALL WA:
Specific phosphorylation of a COOH-terminal site on the full-length
form of the alpha 1 subunit of the skeletal muscle calcium channel by
cAMP-dependent protein kinase. J Biol Chem 267:16100—16105,
1992
23. JAHN H, NASTAINCZYK W, ROHRKASTEN A, SCHNEIDERT, HOFMANN
F: Site-specificphosphorylation of the purified receptor for calcium-
channel blockers by cAMP- and cGMP-dependent protein kinases,
protein kinase C, calmodulin-dependent protein kinase II and casein
kinase II. Eur J Biochem 178:535—542, 1988
24. NUNOKI K, FL0RI0 V, CATTERALL WA: Activation of purified
calcium channels by stoichiometric protein phosphorylation. Proc
NatlAcad Sci USA 86:6816—6820, 1989
25. TANABE T, BEAM KG, POWELL JA, NUMA 5: Restoration of excita-
tion-contraction coupling and slow calcium current in dysgenic
muscle by dihydropyridine receptor complementary DNA. Nature
336:134—139, 1988
26. PEREZ-REYES E, WEI XY, CASTELLANO A, BIRNBAUMER L: Molec-
ular diversity of L-type calcium channels. Evidence for alternative
splicing of the transcripts of three non-allelic genes. J Biol Chem
265:20430—20436, 1990
27. GUY HR, SEETHARAMULU P: Molecular model of the action poten-
tial sodium channel. Proc NatlAcad Sci USA 83:508—512, 1986
28. GRABNER M, FRIEDRICH K, KNAUS HG, STRIESSNIG J, SCHEFFAUER
F, STAUDINGER R, KOCH WJ, SCHWARTZ A, GLOSSMANN H: Calcium
channels from Cyprinus ca/pio skeletal muscle. Proc Nati Acad Sci
USA 88:727—731, 1991
29. CHAUDHARI N: A single nucleotide deletion in the skeletal muscle-
specific calcium channel transcript of muscular dysgenesis (mdg)
mice.J Biol Chem 267:25636—25639, 1992
30. GREGG RG, COUCH F, HOGAN K, POWERS PA: Assignment of the
human gene for the alpha 1 subunit of the skeletal muscle DHP-
sensitive Ca2 channel (CACNL1A3) to chromosome 1q31-q32.
Genomics 15:107—112, 1993
31. CHAUDHARI N: Alternative splicing of mRNA for the skeletal
calcium channel: A direct test. (abstract) Biophys J 66:A319, 1994
32. MALOUF NN, MCMAHON DK, HAINSWORTH CN, KAY BK: A two-
motif isoform of the major calcium channel subunit in skeletal
muscle. Neuron 8:899—906, 1992
33. BIEL M, HULLIN R, FREUNDNER S, SINGER D, DASCAL N, FLOCKERZI
V, HOFMANN F: Tissue-specific expression of high-voltage-activated
dihydropyridine-sensitive L-type calcium channels. Eur J Biochem
200:81—88, 1991
34. KOCH WJ, HUI A, SHULL GE, ELLINOR P, SCHWARTZ A: Character-
ization of eDNA clones encoding two putative isoforms of the alpha
1 subunit of the dihydropyridine-sensitive voltage-dependent calcium
channel isolated from rat brain and rat aorta. FEBS Lett 250:386—
388, 1989
35. NARGEOT J, DASCAL N, LESTER HA: Heterologous expression of
calcium channels. J Membr Biol 126:97—108, 1992
36. PEREZ-REYES E, KIM HS, LACERDA AE, HORNE W, WE! XY, RAMPE
D, CAMPBELL KP, BROWN AM, BIRNBAUMER L: Induction of calcium
currents by the expression of the alpha 1-subunit of the dihydropy-
ridine receptor from skeletal muscle. Nature 340:233—236, 1989
37. LACERDA AE, KIM HS, RUTH P, PEREZ-REYES E, FLOCKERZI V,
HOFMANN F, BIRNBAUMER L, BROWN AM: Normalization of current
kinetics by interaction between the alpha 1 and beta subunits of the
skeletal muscle dihydropyridine-sensitive Ca2 channel. Nature 352:
527—530, 1991
38. GOULD RJ, MURPHY KM, SNYDER SH: Tissue heterogeneity of
calcium channel antagonist binding sites labeled by [3H]nitrendipine.
Mo! Pharmacol 25:235—241, 1984
39. GLOSSMANN H, FERRY DR, GOLL A, STRIESSNIG 3, ZERNIG 0:
Calcium channels and calcium channel drugs: recent biochemical
and biophysical findings. Arzneimittel Forschung 35:1917—1935, 1985
40. Kuo TH, JOHNSON DF, TSANG W, WEINER J: Photoaffinity labeling
of the cardiac calcium channel antagonist receptor in the heart of the
cardiomyopathic hamster. Biochem Biophys Res Commun 148:926—
933, 1987
41. SCHNEIDER T, HOFMANN F: The bovine cardiac receptor for calcium
channel blockers is a 195-kDa protein. Eur J Biochem 174:369—375,
1988
42. CHANG FC, HOSEY MM: Dihydropyridine and phenylalkylamine
receptors associated with cardiac and skeletal muscle calcium chan-
nels are structurally different. J Biol Chem 263:18929—18937, 1988
43. HAASE H, STRIESSNIG J, HOLTZHAUER M, VETTER R, GLOSSMANN H:
A rapid procedure for the purification of cardiac 1,4-dihydropyridine
receptors from porcine heart. Fur J Pharinacol 207:51—59, 1991
44. TOKUMARU H, ANZAI K,ABE T, KIRINO Y: Purification of the cardiac
1,4-dihydropyridine receptor using immunoaffinity chromatography
with a monoclonal antibody against the alpha 2 delta subunit of the
skeletal muscle dihydropyridine receptor. Ear J Phannacol 227:363—
370, 1992
45. HELL JW, YOKOYAMA CT, WONG ST. WARNER C, SNUTCH TP,
CATrERALL WA: Differential phosphorylation of two size forms of
the neuronal class C L-type calcium channel alpha 1 subunit. J Biol
Chem 268:19451—19457, 1993
46. YOSHIDA A, TAKAHASHI M, FUJIMOTO Y, TAKISAWA H, NAKAMURA
T: Molecular characterization of 1,4-dihydropyridine-sensitive cal-
cium channels of chick heart and skeletal muscle. J Biochem 107:
608—612, 1990
47. HAASE H, KARCZEWSKI P, BECKERT R, KRAUSE EG: Phosphorylation
of the L-type calcium channel beta subunit is involved in beta-
adrenergic signal transduction in canine myocardium. FEBS Lett
335:217—222, 1993
48. YOSHIDA A, TAKAHASHI M, NISHIMURA 5, TAKESHIMA H, KOKUBUN
5: Cyclic AMP-dependent phosphorylation and regulation of the
1122 Perez-Reyes and Schneider: Ca24 channels
cardiac dihydropyridine-sensitive Ca channel. FEBS Lett 309:343—
349, 1992
49. MIKAMI A, IMOTO K, TANABE T, NIID0ME T, Mom Y, TAKESHIMA H,
NARUMIYA S, NUMA S: Primary structure and functional expression
of the cardiac dihydropyridine-sensitive calcium channel. Nature
340:230—233, 1989
50. SCHULTZ D, MIKALA G, YATANI A, ENGLE DB, ILES DE, SEGERS B,
SINKE Ri, WEGHUIS DO, KLOCKNER U, WAKAMORI M, WANG J-J,
MELVIN D, VARADI G, SCHWARTZ A: Cloning, chromosomal local-
ization, and functional expression of the alpha 1 subunit of the L-type
voltage-dependent calcium channel from normal human heart. Proc
Nail Acad Sci USA 90:6228—6232, 1993
51. YU AS, HEBERT SC, BRENNER BM, LYTFON J: Molecular character-
ization and nephron distribution of a family of transcripts encoding
the pore-forming subunit of Ca2 channels in the kidney. Proc Nail
Acad Sci USA 89:10494—10498, 1992
52, IWASHIMA Y, PUGH W, DEPAOLI AM, TAKEDA J, SEINO S, BELL GI,
POLONSKY KS: Expression of calcium channel mRNAs in rat pan-
creatic islets and downregulation after glucose infusion. Diabetes
42:948—955, 1993
53. RICH A, KENYON JL, HUME JR, OVERTURF K, HOROWITZ B,
SANDERS KM: Dihydropyridine-sensitive calcium channels expressed
in canine colonic smooth muscle cells. Am J Physiol 264:C745—C754,
1993
54. SOLDATOV NM: Molecular diversity of L-type Ca2 channel tran-
scripts in human fibroblasts. Proc NatI Acad Sci USA 89:4628—4632,
1992
55. LIEVANO A, BOLDEN A, Ho R: Calcium channels in excitable cells:
Divergent genotypic and phenotypic expression of alpha 1-subunits.
Am J Physiol 267:C41 1—C424, 1994
56. CHAUDHARI N, BEAM KG: mRNA for cardiac calcium channel is
expressed during development of skeletal muscle. Dcv Biol 155:507—
515, 1993
57. SNUTCH TP, TOMLINSON Wi, LEONARD JP, GILBERT MM: Distinct
calcium channels are generated by alternative splicing and are
differentially expressed in the mammalian CNS. Neuron 7:45—57,
1991
58. DIEBOLD RJ, KOCH WI, ELLINOR PT, WANG JJ, MUTHUCHAMY M,
WIECZOREK DF, SCHWARTZ A: Mutually exclusive exon splicing of
the cardiac calcium channel alpha I subunit gene generates devel-
opmentally regulated isoforms in the rat heart. Proc NatI Acad Sci
USA 89:1497—1501, 1992
59. FERON 0, OcTAVE JN, CHRISTEN MO, GODFRAIND T: Quantification
of two splicing events in the L-type calcium channel alpha-i subunit
of intestinal smooth muscle and other tissues. Eur J Biochem
222:195—202, 1994
60. WELLING A, KWAN YW, Bosse E, FLOCKERZI V, HOFMANN F, KAss
RS: Subunit-dependent modulation of recombinant L-type calcium
channels. Molecular basis for dihydropyridine tissue selectivity. Circ
Res 73:974—980, 1993
61. KOCH WJ, ELLINOR PT, SCHWARTZ A: eDNA cloning of a dihydro-
pyridine-sensitive calcium channel from rat aorta. Evidence for the
existence of alternatively spliced forms. J Biol Chem 265:17786—
17791, 1990
62. MA Y, KOBRINSKY E, MARKS AR: Cloning and expression of a novel
truncated calcium channel from non-excitable cells. J Biol Chem
270:483—493, 1995
63. WEI XY, PEREZ-REYES E, LACERDA AE, SCHUSTER G, BROWN AM,
BIRNBAUMER L: Heterologous regulation of the cardiac Ca2 chan-
nel alpha 1 subunit by skeletal muscle beta and gamma subunits.
Implications for the structure of cardiac L-type Ca2 channels. JBiol
Chem 266:21943—21947, 1991
64. SINGER D, BIEL M, LOTAN I, FLOCKERZI V, HOFMANN F, DASCAL N:
The roles of the subunits in the function of the calcium channel.
Science 253:1553—1557, 1991
65. BILL M, RuTII P, BOSSE E, HULLIN R, STUIIMER W, FLOCKERZI V,
H0FMAI'1N F: Primary structure and functional expression of a high
voltage activated calcium channel from rabbit lung. FEBS Lett
269:409—412, 1990
66. WAKAMORI M, MIKALA G, SCHWARTZ A, YATANI A: Single-channel
analysis of a cloned human heart L-type Ca2 channel alpha 1
subunit and the effects of a cardiac beta subunit. Biochem Biophys
Res Commun 196:1170—1176, 1993
67. SINGER-LAHAT D, LOTAN I, BIEL M, FLOCKERZI V, HOFMANN F,
DASCAL N: Cardiac calcium channels expressed in Xenopus oocytes
are modulated by dephosphorylation but not by cAMP-dependent
phosphorylation. Receptors Channels 2:215—226, 1994
68. WILLIAMS ME, FELDMAN DH, MCCUE AF, BRENNER R, VELICELEBI
0, ELLIS SB, HARPOLD MM: Structure and functional expression of
alpha 1, alpha 2, and beta subunits of a novel human neuronal
calcium channel subtype. Neuron 8:71—84, 1992
69. LACERDA AE, PEREZ-REYES E, WRI X, CASTELLANO A, BROWN AM:
T-type and N-type calcium channels of Xenopus oocytes: evidence for
specific interactions with beta subunits. Biophys J 66:1833—1843, 1994
70. KLOCKNER U, ITAGAKI K, BoDi I, SCHWARTZ A: Beta-subunit
expression is required for cAMP-dependent increase of cloned
cardiac and vascular calcium channel currents. Pflugers Arch 420:
413—425, 1992
71. HULLIN R, SINGER-LAHAT D, FREICHEL M, BIEL M, DASCAL N,
HOFMANN F, FLOCKERZI V: Calcium channel beta subunit heteroge-
neity: Functional expression of cloned eDNA from heart, aorta and
brain. EMBO J 11:885—890, 1992
72. LACERDA AE, LADNER MB, WEI X, GOPALAKRISHNAN M, PEREZ-
REYES E, BIRNBAUMER L, CLARK R, MCCORMICK F, BROWN AM:
Expression of cardiac Ca2 channel a1 subunit in Sf9 insect cells.
(abstract) Biophys J 61:A245, 1992
73. PURI T, BENSON W, HOSEY MM: Biochemical studies of the dihy-
dropyridine-sensitive rabbit cardiac calcium channel expressed using
the baculovirus/insect cell system. (abstract) Biophys J 64:A319, 1993
74. PEREZ-REYES E, YUAN W, WE! X, BERS DM: Regulation of the
cloned L-type cardiac calcium channel by cyclic-AMP-dependent
protein kinase. FEBS Lett 342:119—123, 1994
75. WELLING A, BossE E, RUTH P, BO'VFLENDER R, FLOCKERZI V,
HOFMANN F: Expression and regulation of cardiac and smooth
muscle calcium channels. Jpn J Phar,nacol 58:258P—262P, 1992
76. LORY P. VARADI G, SLI5H DF, VARADI M, SCHWARTZ A: Charac-
terization of beta subunit modulation of a rabbit cardiac L-type Ca2
channel alpha I subunit as expressed in mouse L cells. FEBS Lett
315:167—172, 1993
77. NISHIMURA 5, TAKESHIMA H, HOFMANN F, FLOCKERZI V. IMoTo K:
Requirement of the calcium channel beta subunit for functional
conformation. FEBS Lett 324:283—286, 1993
78. Hui A, ELLINOR PT, KRIZANOVA 0, WANG JJ, DIEBOLD RJ,
SCHWARTZ A: Molecular cloning of multiple subtypes of a novel rat
brain isoform of the alpha I subunit of the voltage-dependent
calcium channel. Neuron 7:35—44, 1991
79. So 5, CHEN L, SEIN0 M, BLONDEL 0, TAKEDA J, JOHNSON JH,
BELL GI: Cloning of the alpha 1 subunit of a voltage-dependent
calcium channel expressed in pancreatic beta cells. Proc Nati Acad
Sci USA 89:584—588, 1992
80. YANEY GC, WHEELER MB, WEI XY, PEREZ-REYES E, BIRNBAUMER
L, BOYD AE, Moss LG: Cloning of a novel alpha 1-subunit of the
voltage-dependent calcium channel from the beta-cell. Mol Endocri-
nol 6:2143—2152, 1992
81. CHIN HM, KOZAK CA, KIM HL, MOCK B, MCBRIDE OW: A brain
L-type calcium channel alpha 1 subunit gene (CCHLIA2) maps to
mouse chromosome 14 and human chromosome 3. Genomics Ii:
914—919, 1991
82. OSHEROV A, GOLDBERG D, AmA5 D: Is the neuronal voltage-
sensitive calcium channel of human brain, human pancreatic beta
cells and rat brain much larger than predicted by its cDNA se-
quence? Neurosci Lett 147:233—235, 1992
83. CHIN H, SMITH MA, KIM HL, KIM H: Expression of dihydropyridine-
sensitive brain calcium channels in the rat central nervous system.
FEBS Lett 299:69—74, 1992
84. MORI Y, FRIEDRICH T, KIM MS, MIKAMI A, NAKAI J, RUTH P, BOSSE
E, HOFMANN F, FLOCKERZI V, FURUICHI T, MIKOSHIBA K, IMOTO K,
TANABE T, NUMA 5: Primary structure and functional expression
from complementary DNA of a brain calcium channel. Nature
350:398—402, 1991
85. STARR TV, PRYSTAY W, SNUTCH TP: Primary structure of a calcium
channel that is highly expressed in the rat cerebellum. Proc NatlAcad
Sci USA 88:5621—5625, 1991
86. STEA A, T0MLIN50N Wi, SooNu TW, BOURINET E, DUBEL Si,
VINCENT SR, SNUTCH TP: Localization and functional properties of
a rat brain alpha 1A calcium channel reflect similarities to neuronal
Perez-Reyes and Schneider: Ca2 channels 1123
Q- and P-type channels. Proc Nat! Acad Sci USA 9 1:10576—10580,
1994
87. OLCESE R, QIN N, SCHNEIDER T, NEELY A, WEI X, STEFANT F,
BIRNBAUMER L: The amino terminus of a calcium channel beta
subunit sets rates of channel inactivation independently of the
subunit's effect on activation. Neuron 13:1433—1438, 1994
88. WHEELER DB, RANDALL A, TSIEN RW: Roles of N-type and 0-type
Ca2 channels in supporting hippocampal synaptic transmission.
Science 264:107—111, 1994
89. LLINAS R, SuGIM0RI M, HILLMAN DE, CHERSKEY B: Distribution
and functional significance of the P-type, voltage-dependent Ca2
channels in the mammalian central nervous system. Trends Neurosci
15:351—355, 1992
90. SATHER WA, TANABE T, Z1-IANG JF, MORI Y, ADAMS ME, TSIEN
RW: Distinctive biophysical and pharmacological properties of class
A (BI) calcium channel alpha 1 subunits. Neuron 11:291—303, 1993
91. MINTZ TM, VENEMA VJ, SWIDEREK KM, LEE TD, BEAN BP, ADAMS
ME: P-type calcium channels blocked by the spider toxin omega-aga-
IVA. Nature 355:827—829, 1992
92. ZHANG JF, RANDALL AD, ELLINOR PT, HORNE WA, SATHER WA,
TANABE T, SCHWARZ TL, TSIEN RW: Distinctive pharmacology and
kinetics of cloned neuronal Ca2 channels and their possible coun-
terparts in mammalian ens neurons. Neurophannaco!ogy 32:1075—
1088, 1993
93. MCENERY MW, SNOWMAN AM, SHARP AH, ADAMS ME, SNYDER
SH: Purified omega-conotoxin GVIA receptor of rat brain resembles
a dihydropyridine-sensitive L-type calcium channel. Proc Nat! Acad
Sci USA 88:11095—11099, 1991
94. WITCHER DR, DE WAARD M, SAKAMOTO J, FRANZINI-ARMSTRONG
C, PRAGNELL M, KAHL SD, CAMPBELL KP: Subunit identification and
reconstitution of the N-type Ca2 channel complex purified from
brain. Science 261:486—489, 1993
95. DE WAARD M, WITCI-IER DR, CAMPBELL KP: Functional properties
of the purified N-type Ca2 channel from rabbit brain. J Bio! Chem
269:6716—6724, 1994
96. LEVEQUE C, EL FAR 0, MARTIN-MOUTOT N, SAT0 K, KATO R,
TAKAI-IASHI M, SEAGAR MJ: Purification of the N-type calcium
channel associated with syntaxin and synaptotagmin. A complex
implicated in synaptic vesicle exocytosis.JBiol Chem 269:6306—6312,
1994
97. MCENERY MW, SNOWMAN AM, SNYDER SH: Evidence for subtypes
of the omega-conotoxin GVIA receptor. Identification of the prop-
erties intrinsic to the high-affinity receptor. Ann NY Acad Sci
635:435—437, 1991
98. HESCHELER J, ROSENTHAL W, TRAUTWEIN W, SCHULTZ G: The
GTP-binding protein, Go, regulates neuronal calcium channels.
Nature 325:445—447, 1987
99. MENONJOHANSSON AS, BERROW N, DOLPHIN AC: G(o) transduces
GABA(b)-receptor modulation of N-type calcium channels in cul-
tured dorsal root ganglion neurons. Pflugers Arch 425:335—343, 1993
100. YATANI A, IMOTO Y, CODINA J, HAMILTON SL, BROWN AM, BIRN-
BAUMER L: The stimulatory G protein of adenylyl cyclase, Gs, also
stimulates dihydropyridine-sensitive Ca2F channels. Evidence for
direct regulation independent of phosphorylation by cAMP-depen-
dent protein kinase or stimulation by a dihydropyridine agonist. J
Biol Chem 263:9887—9895, 1988
101. SAKAMOTO J, CAMPBELL KP: A monoclonal antibody to the beta
subunit of the skeletal muscle dihydropyridine receptor immunopre-
cipitates the brain omega-c000toxin GVIA receptor. J Bio! Chem
266:18914—18919, 1991
102. WILLIAMS ME, BRUST PF, FELDMAN DH, PAt-rHI S, SIMERSON 5,
MAROUFI A, MCCUE AF, VELICELEBI G, ELLIS SB, HARPOLD MM:
Structure and functional expression of an omega-conotoxin-sensitive
human N-type calcium channel. Science 257:389—395, 1992
103. DUBEL SJ, STARR TV, HELL J, AHLIJANIAN MK, ENYEART JJ,
CATFERALL WA, SNUTCH TP: Molecular cloning of the alpha-I
subunit of an omega-conotoxin-sensitive calcium channel. Proc Nat!
Acad Sci USA 89:5058—5062, 1992
104. FUJITA Y, MYNLIEFF M, DIRKSEN RT, KIM MS, NIIDOME T, NAKAI J,
FRIEDRICH T, IWABE N, MIYATA T, FURUICHI T, FURUTAMA D,
MIKOSHIBA K, M0RI Y, BEAM KG: Primary structure and functional
expression of the omega-conotoxin-sensitive N-type calcium channel
from rabbit brain. Neuron 10:585—598, 1993
105. COPPOLA T, WALDMANN R, BoRSoyro M, HEURTEAUX C, ROMEY G,
MATTEl MG, LAZDUNSKI R: Molecular cloning of a murine N-type
calcium channel al subunit - Evidence for isoforms, brain distribu-
tion, and chromosomal localization. FEBS Lett 338:1—5, 1994
106. HORNE WA, HAWROT E, TSIEN RW: omega-Conotoxin GVIA
receptors of Discopyge electric organ. Characterization of omega-
conotoxin binding to the nicotinic acetylcholine receptor. J Biol
Chem 266:13719—13725, 1991
107. STEA A, DUBEL Si, PRAGNELL M, LEONARD JP, CAMPBELL KP,
SNUTCH TP: A beta-subunit normalizes the electrophysiological
properties of a cloned N-type Ca2 channel alpha(1)-subunit. Neu-
ropharmacology 32:1103—1116, 1993
108. BRUST PF, SIMERSON S, MCCUE AF, DEAL CR, SCHOONMAKER S,
WILLIAMS ME, VELICELEBI G, JOHNSON EC, HARPOLD MM, ELLIS
SB: Human neuronal voltage-dependent calcium channels-Studies
on subunit structure and role in channel assembly. Neuropharmaco!-
ogy 32:1089—1102, 1993
109. NIIDOME T, KIM MS, FRIEDRICI-I T, M0RI Y: Molecular cloning and
characterization of a novel calcium channel from rabbit brain. FEBS
Lett 308:7—13, 1992
110. SOONG TW, STEA A, HODSON CD, DUBEL Si, VINCENT SR, SNUTCH
TP: Structure and functional expression of a member of the low
voltage-activated calcium channel family. Science 260:1133—1136,
1993
111. HORNE WA, ELLINOR PT, INMAN I, ZHOU M, T5IEN RW, SCHWARZ
TL: Molecular diversity of Ca2 channel alpha 1 subunits from the
marine ray Discopyge ommata. Proc Nat!Acad Sci USA 90:3787—3791,
1993
112. SCHNEIDER T, WET X, OLCESE R, COSTANTIN JL, NEELY A, PALADE
P, PEREZ-REYES F, QIN N, ZHOU J, CRAWFORD GD, SMITH RG,
APPEL SH, STEFAM E, BIRNBAUMER L: Molecular analysis and
functional expression of the human type E cx subunit. Receptors and
Channe!s 2:255—270, 1995
113. WILLIAMS ME, MARUBIO LM, DEAL CR, HANS M, BRUST PF,
PHILIPSON LH, MILLER RJ, JOHNSON EC, HARPOLD MM, ELLIS SB:
Structure and functional characterization of neuronal alpha 1E
calcium channel subtypes. J Bio! Chem 269:22347—22357, 1994
114. ELLINOR PT, ZHANG J-F, RANDALL AD, ZHOU M, SCHWARZ TL,
TSIEN RW, HORNE WA: Functional expression of a rapidly inacti-
vating neuronal calcium channel. Nature 363:455—458, 1993
115. TSIEN RW, LIPSCOMBE D, MADISON DV, BLEY KR, Fox AP:
Multiple types of neuronal calcium channels and their selective
modulation. Trends Neurosci 11:431—438, 1988
116. REGAN U, SAH DWY, BEAN BP: Ca2 channels in rat central and
peripheral neurons: high threshold current resistant to dihydropyri-
dine blockers and omega-conotoxin. Neuron 6:269—280, 1991
117. NAKAYAMA N, KIRLEY TL, VAGHY PL, MCKENNA E, SCHWARTZ A:
Purification of putative Ca2 channel protein from rabbit skeletal
muscle. Determination of the amino-terminal sequence. J Biol Chem
262:6572—6576, 1987
118. KIM HS: Expression and characterization of rabbit skeletal muscle
dihydropyridine receptor/calcium channel components in mamma-
lian cells. (Ph.D. Thesis) Baylor College of Medicine, Houston,
Texas, 1992
119. ILES DE, LEHMANN-HORN F, SCHERER SW, TsuI LC, OLDE WEGHUIS
D, SUIJKERBUIJK RF, HEYTENS L, MIKALA G, SCHWARTZ A, ELLIS
FR, STEWART AD, DEUFEL T, WIERINGA B: Localization of the gene
encoding the alpha 2/delta-subunits of the L-type voltage-dependent
calcium channel to chromosome 7q and analysis of the segregation of
flanking markers in malignant hyperthermia susceptible families.
Hum Mo! Genet 3:969—975, 1994
120. DE JONGH KS, WARNER C, CATITERALL WA: Subunits of purified
calcium channels. Alpha 2 and delta are encoded by the same gene.
J Bio! Chem 265:14738—14741, 1990
121. JAY SD, SHARP AH, KARL SD, VEDVICK TS, HARPOLD MM,
CAMPBELL KP: Structural characterization of the dihydropyridine-
sensitive calcium channel alpha 2-subunit and the associated delta
peptides. J Bio! Chem 266:3287—3293, 1991
122. SINGER-LAHAT D, LOTAN I, ITAGAKI K, SCHWARTZ A, DASCAL N:
Evidence for the existence of RNA of Ca2-channel alpha 2/delta
subunit in Xenopus oocytes.Biochim Biophys Acta 1137:39—44, 1992
123. KIM HL, KIM H, LEE P, KING RG, CHIN H: Rat brain expresses an
alternatively spliced form of the dihydropyridine-sensitive L-type
1124 Perez-Reyes and Schneider: Ca2 channels
calcium channel alpha 2 subunit. Proc NatlAcad Sci USA 89:3251—
3255, 1992
124. WELLING A, BOSSE E, CAVALIE A, BOTFLENDER R, LUDWIG A,
NASTA!NCZYK W, FI,oc1uRzI V, HOFMANN F: Stable co-expression of
calcium channel alpha(1), beta and alpha(2/delta) subunits in a
somatic cell line. J Physiol 471:749—765, 1993
125. POWERS PA, Lb S, HOGAN K, GREGG RG: Molecular characteriza-
tion of the gene encoding the gamma subunit of the human skeletal
muscle 1,4-dihydropyridine-sensitive Ca2 channel (CACNLG),
eDNA sequence, gene structure, and chromosomal location. J Biol
Chem 268:9275—9279, 1993
126. ILES DE, SEGERS B, WEGFIUIS DO, SUIKERBUIJK R, WIERINGA B:
Localization of the gamma-subunit of the skeletal muscle L-type
voltage-dependent calcium channel gene (CACNLG) to human
chromosome band 17q24 by in Situ hybridization and identification of
a polymorphic repetitive DNA sequence at the gene locus. Cytogenel
Cell Genet 64:227—230, 1993
127. LEUNG AT, IMAGAWA T, BLOCK B, FRANZINI-ARMSTRONG C, CAMP-
BELL KP: Biochemical and ultrastructural characterization of the
1,4-dihydropyridine receptor from rabbit skeletal muscle. Evidence
for a 52,000 Da subunit. J Biol Chem 263:994—1001, 1988
128. NASTAINCZYK W, ROHRKASTEN A, SIEBER M, RUDOLPH C, SCHACHT-
ELF C, MARME D, HOFMANN F: Phosphorylation of the purified
receptor for calcium channel blockers by cAMP kinase and protein
kinase C. EurfBiochem 169:137—142, 1987
129. C0LLIN T, WANG JJ, NARGEOT J, SCHWARTZ A: Molecular cloning of
three isoforms of the L-type voltage-dependent calcium channel beta
subunit from normal human heart. Circ Res 72:1337—1344, 1993
130. POWERS PA, Liu 5, HOGAN K, GREGG RG: Skeletal muscle and brain
isoforms of a beta-subunit of human voltage-dependent calcium
channels are encoded by a single gene. J Biol Chem 267:22967—22972,
1992
131. GREGG RG, POWERS PA, HOGAN K: Assignment of the human gene
for the beta subunit of the voltage-dependent calcium channel
(CACNLB1) to chromosome 17 using somatic cell hybrids and
linkage mapping. Genomics 15:185—187, 1993
132. PEREZ-REYES E, CASTELLANO A, KIM HS, BERTRAND P, BAOGSTROM
E, LACERDA AE, WE! XY, BIRNBAUMER L: Cloning and expression
of a cardiac/brain beta subunit of the L-type calcium channel. J Biol
Chem 267:1792—1797, 1992
133. ROSENFELD MR, WONG E, DALMAU J, MANLEY G, POSNER JB, SHER
E, FURNEAUX HM: Cloning and characterization of a Lambert-
Eaton myasthenic syndrome antigen. Ann Neurol 33:113—120, 1993
134. CASTELLANO A, WE! XY, BIRNBAUMER L, PEREZ-REYES E: Cloning
and expression of a third calcium channel beta subunit. J Biol Cheni
268:3450—3455, 1993
135. C0LLIN T, LORY P, TAVIAUX 5, COURTIEU C, GUII,BAULT P, BERTA P,
NARGEOT J: Cloning, chromosomal location and functional expres-
sion of the human voltage-dependent calcium channel 133 subunit.
Eur J Biochem 220:257—262, 1994
136. CASTELLANO A, WE! XY, BIRNBAUMER L, PEREZ-REYES E: Cloning
and expression of a neuronal calcium channel beta subunit. J Biol
Chem 268:12359—12366, 1993
137. MI'I-!'ERDORFER J, FROSCHMAYR M, GRABNER M, STRIESSN!G J,
GLOSSMAN H: Calcium channels: The 13-subunit increases the affinity
of dihydropyridines and Ca2 binding sites of the a1 subunit. FEBS
Lett 352:141—145, 1994
138. NEELY A, WE! X, OLCESE R, BIRNBAUMER L, STEFANI F: Potentia-
tion by the beta subunit of the ratio of the ionic current to the charge
movement in the cardiac calcium channel. Science 262:575—578, 1993
139. PRAGNEIJ. M, DE WAARD M, M0R! Y, TANABE T, SNUTCH TP,
CAMPBELL KP: Calcium channel beta-subunit binds to a conserved
motif in the I-Il cytoplasmic linker of the alpha 1-subunit. Nature
368:67—70, 1994
140. DE WAARD M, PRAGNELL M, CAMPBELL KP: Ca2 channel regula-
tion by a conserved beta subunit domain. Neuron 13:495—503, 1994
141. KIM M-S, M0RI! T, SUN L-X, IM0TO K, M0R! Y: Structural deter-
minants of ion selectivity in brain calcium channel. FEBS Lett
318:145—148, 1993
142. TANG S, MIKALA G, BAH!NSK! A, YATAN! A, VARADI G, SCHWARTZ
A: Molecular localization of ion selectivity sites within the pore of a
human L-type cardiac calcium channel. J Biol Chem 268:13026—
13029, 1993
143. YANG J, ELLINOR PT, SATHER WA, ZHANG JF, TS!EN RW: Molecular
determinants of Ca2 selectivity and ion permeation in L-type Ca2
channels. Nature 366:158—161, 1993
144. TANABE T, BEAM KG, ADAMS BA, NHDOME T, NUMA S: Regions of
the skeletal muscle dihydropyridine receptor critical for excitation-
contraction coupling. Nature 346:567—569, 1990
145. TANABE T, ADAMS BA, NUMA S, BEAM KG: Repeat I of the
dihydropyridine receptor is critical in determining calcium channel
activation kinetics. Nature 352:800—803, 1991
146. N\xAI J, ADAMS BA, IMoTo K, BEAM KG: Critical roles of the S3
segment and S3-S4 linker of repeat-I in activation of L-type calcium
channels. Proc NatlAcad Sci USA 91:1014—1018, 1994
147. ZHANG iF, ELLINOR PT, ALDRICH RW, TSIEN RW: Molecular
determinants of voltage-dependent inactivation in calcium channels.
Nature 372:97—100, 1994
148. DE LEON M, JONES L, PEREZ-REYES E, WE! X, SNUTCH T, SOONG
WS, YuE DT: An essential Ca2-binding motif for Ca2-sensitive
inactivation of L-type Ca channels. (manuscript submitted)
149. REGULLA S. SCHNEIDER T, NASTAINCZYK W, MEYER HE, HOFMANN
F: Identification of the site of interaction of the dihydropyridinc
channel blockers nitrendipine and azidopine with the calcium-
channel alpha 1 subunit. EMBO J 10:45—49, 1991
150. STRIESSNICI J, MURPHY BJ, CATTERALL WA: Dihydropyridine recep-
tor of L-type Ca2 channels: Identification of binding domains for
[3Hj(+)-PN200—110 and [3Hjazidopine within the alpha 1 subunit.
Proc NatlAcad Sci USA 88:10769—10773, 1991
151. TANG 5, YATAN! A, BAHINSKI A, MORI Y, SCHWARTZ A: Molecular
localization of regions in the L-type calcium channel critical for
dihydropyridine action. Neuron 11:1013—1021, 1993
152. KiM HS, WE! XY, RUTH P, PEREZ-REYES E, FLOCKERZJ V, HOF-
MANN F, BIRNBAUMER L: Studies on the structural requirements for
the activity of the skeletal muscle dihydropyridine receptor/slow
Ca2 channel. Allosteric regulation of dihydropyridine binding in the
absence of alpha 2 and beta components of the purified protein
complex. J Biol Chem 265:11858—11863, 1990
153. ITAGAJU K, KOCH Wi, B0DI I, KLOCKNER U, SLISH DF, SCHWARTZ A:
Native-type DHP-sensitive calcium channel currents are produced by
cloned rat aortic smooth muscle and cardiac alpha 1 subunits
expressed in Xenopus laevis oocytes and arc regulated by alpha 2-
and beta-subunits. FEBS Lett 297:221—225, 1992
154. MA Wi, H0IZ RW, UBLER MD: Expression of a eDNA for a
neuronal calcium channel alpha 1 subunit enhances secretion from
adrenal chromaffin cells. J Biol Qiem 267:22728—22732, 1992
155. TOMI.INS0N WJ, SlEA A, BOURINET E, CHARNET P, NARGEOT 1,
SNUTCH TP: Functional properties of a ncuronal class-c L-type
calcium channel. Neuropharmacology 32:1117—1126, 1993
156. PRAGNELL M, SAKAMOTO J, JAY SD, CAMPBELL KP: Cloning and
tissue-specific expression of the brain calcium channel beta-subunit.
FEBS Leo 291:253—258, 1991
